CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues

Leukemia and Lymphoma

Volumn 24, Issue 5-6, 1997, Pages 393-422

  Gruss, Hans Jürgen ^a   Herrmann, Friedhelm ^a   Gattei, Valter ^b   Gloghini, Annunziata ^b   Pinto, Antonio ^b   Carbone, Antonino ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

CD40; CD40 ligands; Hematopoietic malignancy; Malignant lymphomas; Reactive tissues

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN M; MEMBRANE PROTEIN; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; APOPTOSIS; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BASOPHIL; DENDRITIC CELL; ENDOTHELIUM CELL; EOSINOPHIL; EPITHELIUM CELL; GENE MUTATION; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; MAST CELL; MEMORY CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REED STERNBERG CELL; REVIEW; SEQUENCE HOMOLOGY; STROMA CELL; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL;

EID: 0030937548     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709055580     Document Type: Review

References (236)

1. Clark, E. A. and Ledbetter, J. A. (1986). Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl Acad. Sci. USA. 83, 4494-4498.
2. Stamenkovic, I., Clark, E. A. and Seed, B. (1989). A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J., 8, 1403-1410.
3. Smith, C. A., Farrah, T. and Goodwin, R. G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death Cell,75, 959-962.
4. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.-P., van Kooten, C., Liu, Y. J., Rousset, F. and Saeland, S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol., 12, 881-922.
5. Gruss, H.-J. and Dower, S. K. (1995). TNF ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404
6. Torres, R. M. and Clark, E. A. (1992). Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J. Immunol., 148, 620-628.
7. Mallett, S. and Barclay, A. N. (1991). A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today, 12, 220-223.
8. Bazan, J. F. (1993). Emerging families of cytokines and receptors. Curr. Biol.,3, 603-606.
9. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H. and Lesslauer, W. (1993). Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex, implications for TNF receptor activation. Cell. 73, 431-445.
10. Grimaldi, J. C., Torres, R., Kozak, C. A., Chang, R., Clark, E. A., Howard, M. and Cockayne, D. A. (1992). Genomic structure and chromosomal mapping of the munne CD40 gene. J. Immunol. 149, 3921-3926
11. Ramesh, N., Ramesh, V., Gusella, J. F. and Geha, R. (1993). Chromosomal localization of the gene for human B cell antigen CD40. Somatic Cell. Mol. Gen., 19, 295-298.
12. Lafage-Poitchaloff, T. M., Herman, P., Birg, F., Galizzi, J. P., Simonetti, J., Mannoni, P. and Banchereau, J. (1994). Localization of the human CD40 gene to chromosome 20. bands q12-q13.2. Leukemia. 8, 1172-1175.
13. Feinstein, E., Kimchi, A., Wallach, D., Boldin, M. and Varfolomeev, E. (1995). The death domain: a module shared by proteins with diverse cellular functions. Trends Biolog. Sci., 20, 342-344.
14. Itoh, N. and Nagata, S. (1993). A novel protein domain required for apoptosis Mutational analysis of human Fas antigen. J. Biol. Chem., 268, 10932-10937
15. Tartaglia, L. A., Ayres, T. M., Wong, G. H. W. and Goeddel. D. V. (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74, 845-853.
16. Gravestein, L. A., Blorn, B., Nolten, L. A., de Vries, E., van der Horst, G., Ossendorp, F., Borst, J. and Loenen, W. A. M. (1993). Cloning and expression of murine CD27: comparison with 4-1BB. another lymphocyte-specific member of the nerve growth factor receptor family. Eur. J. Immunol., 23, 943-950.
17. Vandenabeele, P., Declercq, W., Beyaert, R. and Fiers. W. (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol., 5, 392-399.
18. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
19. Hu, H. M., O'Rourke, K., Boguski, M. S. and Dixit, V. M. (1994). A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem., 269, 30069-30072.
20. Rothe, M., Sarma, V., Dixit, V. M. and Goeddel, D. V. (1995). TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science, 269, 1424-1427.
21. Ware, C. F., VanArsdale, S and VanArsdale, T. L. (1996). Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem., 60, 47-55.
22. Uckun, F. M., Schieven, G. L., Diberdik, I., Chandan-Langlie, M., Tuel-Ahlgren, L. and Ledbetter, J. A. (1991). Stimulation of protein tyrosine phosphorylation, phosophoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem., 266, 17478-17485.
23. Inui, S., Kaisho, T., Kikutani, H., Stamenkovic, I., Seed, B., Clark, E. A. and Kishimoto, T. (1990). Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol., 20, 1747-1753.
24. Kansas, G. S. and Tedder, T. F. (1991). Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol., 147, 4094-4102.
25. Ren, C. L., Morio, T., Fu, S. F and Geha, R. S. (1994). Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med.,179, 673-680.
26. Knox, K. A. and Gordon, J. (1993) Protein tyrosine phosphorylation is mandatory for CD40 mediated rescue of germinal center B cells from apoptosis. Eur. J. Immunol., 23, 2578-2584.
27. Faris, M., Gaskin, F., Parsons, T. and Fu, S. M. (1994). CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase lyn, fyn, and syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp Med., 179, 1923-1931.
28. Berberich, I., Shu, G., Siebelt, F., Woodgett, J. R., Kyriakis, J. M. and Clark, E. A. (1996). Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J., 15, 92-101.
29. Berberich, I., Shu, G. L and Clark, E. A. (1994). Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol., 153, 4357-4366.
30. Francis, D. A., Karras, J. G., Ke, X., Sen, R. and Rothstein, T. L. (1995). Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol., 7, 151-161.
31. Clark, E. A. and Ledbetter, J. A. (1994). How B and T cells talk to each other. Nature, 367, 425-428.
32. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith. C. A., Grabstein, K. H., Cosman, D. and Spriggs, M. K. (1992). Molecular and biological characterization of a murine ligand for CD40. Nature, 357, 80-82.
33. Spriggs, M. K., Armitage, R. J., Strockbine, L., Clifford, K. N., Macduff, B. M., Sato, T. A., Maliszewski, C. R. and Fanslow, W. C. (1992). Recombinant human CD40 ligand stimulates B cell proliferation and Immunoglobulin E secretion. J. Exp. Med., 176, 1543-1550.
34. Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny. N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A. and Aruffo, A. (1992). The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J., 11, 4313-4321.
35. Gauchat, J. F., Aubry, J. P., Mazzei, G., Life, P., Jomotte, T., Elson, G. and Bonnefoy, J. Y. (1993). Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett., 315, 259-266.
36. Graf, D., Korthäuer, U., Mages, H. W., Senger, G. and Kroczek, R. A. (1992). Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol.22, 3191-3194.
37. Cocks, B. G., de Waal Malefyt, R., Galizzi, J. P., de Vries, J. E. and Aversa, G. (1993). IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol., 5, 657-663.
38. Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavecchia, A. and Gray, D. (1992). Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol.,22, 2573-2578.
39. Graf, D., Muller, S., Korthäuer, U., van Kooten, C., Weise, C. and Kroczek, R. A. (1995). A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation Eur. J. Immunol.,25, 1749-1754.
40. Jones, E. Y., Stuart, D. I. and Walker, N. P. C. (1989). Structure of tumour necrosis factor. Nature. 338, 225-228.
41. Peitsch, M. C. and Jongeneel, C. V. (1993). A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol.,5, 233-238.
42. Karpusas, M., Hsu, Y.-M., Wang, J.-H., Thompson, J., Lederman, S., Chess, L. and Thomas, D. (1995). 2Å crystal structure of an extracellular fragment of human CD40 ligand. Structure,3, 1031-1039.
43. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. and Goodwi, R. G. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis Immunity, 3, 673-682.
44. Browning, J. L., Ngam-ek, A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E. P., Hession, C., O'Brien-Greco, B., Foley, S. F. and Ware, C. F. (1993) Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell, 72, 847-856.
45. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Goodwin. R. G. and Smith, C. A. (1994). A lymphotoxin-β-specific receptor. Science, 264, 707-710.
46. Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B. and Goeddel, D. V. (1984). Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 312, 724-729.
47. Suda, T., Takahashi, T. Golstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75, 1169-1178.
48. Gruss, H.-J. and Herrmann, F. (1996) CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control for CD30+ lymphoid and lymphoma cells. Leuk Lymphoma, 20, 387-409.
49. Kriegler, M., Perez, C., DeFay, K., Albert, I. and Lu, S. D. (1988). A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell.53, 45-53
50. Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarrett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., Palladino, M. A. and Nedwin, G. E. (1984). Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature, 312, 721-724.
51. Tanaka, M., Suda, T., Takahashi, T and Nagata, S. (1995). Expression of the functional soluble form of human FAS ligand in activated lymphocytes. EMBO J., 14, 1129-1135.
52. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., Fanslow, W. C., Belmont, J. and Spriggs, M. K. (1993). CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science, 259, 990-993.
53. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., Roberts, R. L., Noelle, R. J., Ledbetter, J. A., Francke, U. and Ochs, H. D. (1993). The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72, 291-300.
54. Callard, R. E., Armitage, R. J., Fanslow, W. C. and Spriggs, M. K. (1993). CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today, 14, 559-564.
55. Conley, M. E. (1992). Molecular approaches to analysis of X-linked immunodeficiencies. Anna. Rev. Immunol., 10, 215-238.
56. Padayachee, M., Feighery, C., Finn, A., McKeown, C., Levinsky, R. J., Kinnon, C. and Malcolm, S. (1992). Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics, 14, 551-553.
57. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, R. S., Chatila, T., Fu, S. M., Stamenkovic, I. and Geha, R. S. (1993). Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl. Acad Sci. USA. 90, 2170-2173.
58. Korthäuer, U., Graf, D., Mages, H. W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J. and Kroczek, R. A. (1993). Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper IgM Nature. 361, 539-541.
59. DiSanto, J. P., Bonnefoy, J. Y., Gauchat, J. F., Fischer, A. and de Saint Basile, G. (1993). CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature, 361, 541-543.
60. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T. and Kikutani, H. (1994). The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1, 167-178.
61. Renshaw, B., Fanslow, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B and Maliszewski, C. R. (1994). Humoral immune responses in CD40 ligand deficient mice. J. Exp. Med., 180, 1889-1900.
62. Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore. J., Noelle, R. J. and Flavell, R. A. (1994). Mice deficient for the CD40 ligand. Immunity, 1, 423-431.
63. Foy, T. M., Shepherd, D. M., Durie, F. H., Aruffo, A., Ledbetter. J. A. and Noelle, R. J. (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med., 178, 1567-1575.
64. Foy, T. M., Laman, J. D., Ledbetter, J. A., Aruffo, A., Claassen, E. and Noelle, R. J. (1994). gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med., 180, 157-163.
65. Gray, D., Dullforce, P. and Jamandunsing, S. (1994). Memory B cell development but not germinal center formation is impaired by in vivo blockage of CD40-CD40L interaction. J. Exp. Med., 180, 141-155.
66. Gray, D., Siepmann, K. and Wohlleben, G. (1994). CD40 ligation in B cell activation, isotype switching and memory development. Semin. Immunol.,6, 303-310.
67. Liu, Y. J., de Bouteiller, O., Arpin, C., Durand, I. and Banchereau. J. (1993). Five human mature B cell subsets. Adv. Exp. Med. Biol., 355, 289-296.
68. Quiding-Jarbrink, M., Lakew, M., Nordstrom, I., Banchereau, J., Butcher, E., Holmgren, J and Czerkinsky, C. (1995). Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur. J. Immunol., 25, 322-327.
69. Ledbetter, J. A., Shu, G., Gallagher, M. and Clark, E. A. (1987). Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDw40). J. Immunol., 138, 788-794.
70. Valle, A., Zuber, C. E., Defrance, T., Djossou, O., DeRie, M. and Banchereau, J. (1989). Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol, 19, 1463-1467.
71. Uckun, F. M., Gajl-Peczalska, K., Myers, D. E., Jaszcz, W., Haissig, S. and Ledbetter, J. A. (1990) Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-Imeage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood. 76, 2449-2456.
72. Law, C.-L., Wörmann, B. and LeBien. T. W. (1990). Analysis of expression and function of CD40 on normal and leukemic human B cell precursors Leukemia, 4, 732-738.
73. Paulie, S., Ehlin-Henriksson, B., Mellstedt, H., Koho, H., Ben-Aissa, H. and Perlmann. P. (1985). A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother., 20, 23-28.
74. van Kooten, C., Gaillard, C., Galizzi, J.-P., Hermann, P., Fossiez, F., Banchereau, J. and Blanchard, D. (1994). B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol., 24, 787-792.
75. Gordon, J., Millsum, M. J., Guy, G. R. and Ledbetter, J. A. (1988). Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. J. Immunol., 140, 1425-1430.
76. Björck, P., Axelsson, B. and Paulie, S. (1991). Expression of CD40 and CD43 during activation of human B lymphocytes. Scand. J. Immunol., 33, 211-218.
77. Kansas, G. S., Wood, G. S. and Tedder, T. F. (1991). Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J. Immunol., 146, 2235-2344.
78. Barrett, T. B., Shu, G. and Clark, E. A. (1991). CD40 signaling activates CD11a/CD 18 (LFA-1 (-mediated adhesion in B cells. J. Immunol., 146, 1722-1729.
79. Flores-Romo, L., Estoppey, D. and Bacon, K. B. (1993) Anti-CD40 antibody stimulates the VLA-4-dependent adhesion of normal and LFA-1-deficient B cells to endothelium. Immunol., 79, 445-451.
80. Liu, Y.-J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J. and MacLennan, I. C. M. (1989). Mechanism of antigen-driven selection in germinal centres. Nature, 342, 929-931.
81. Liu, Y. J., Mason, D. Y., Johnson, G. D., Abbot, S., Gregory, C. D., Hardie, D. L., Gordon, J. and MacLennan. I. C. (1991). Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol., 21, 1905-1910.
82. Holder, M. J., Wang, H., Milner, A. E., Casamayor, M., Armitage, R., Spriggs, M. K., Fanslow, W. C., MacLennan, I. C. M., Gregory, C. D. and Gordon, J. (1993). Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol., 23, 2368-2371.
83. Grabstein, K. H., Maliszewski, C. R., Shanebeck, K., Sato, T. A., Spriggs, M. K., Fanslow, W. C. and Armitage, R. J. (1993). The regulation of T cell-dependent antibody formation in vitro by CD40 Hgand and IL-2. J. Immunol., 150, 3141-3147.
84. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med., 175, 1091-1101.
85. Armitage, R. J., Macduff, B. M., Spriggs, M. K. and Fanslow, W. C. (1993). Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol., 150, 3671-3680.
86. Ranheim, E. A. and Kipps, T. J. (1993). Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med., 177, 925-935.
87. Maliszewski, C. R., Grabstein, K., Fanslow, W. C., Armitage, R., Spriggs, M. K. and Sato, T. A. (1993). Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines Eur. J. Immunol., 23, 1044-1049
88. Kennedy, M. K., Mohler, K. M., Shanebeck, K. D., Baum, P. R., Picha, K. S., Otten-Evans, C. A., Janeway Jr., C. A. and Grabstein, K. H. (1994). Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol., 24, 116-123.
89. Clark, E. A. and Shu, G. (1990). Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol., 145, 1400-1406.
90. Burdin, B., Peronne, C., Banchereau, J. and Rousset, F. (1993). Epstein-Barr virus-transformation induces B lymphocytes to produce human interleukin-10 J. Exp. Med., 177, 295-304.
91. Worm, M. and Geha, R. S. (1994). CD40 ligation induces lymphotoxin α gene expression in human B cells Int. Immunol.,6, 1883-1890.
92. Banchereau, J., de Paoli, P., Vallé, A., Garcia, E. and Rousset, F. (1991) Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 251, 70-72.
93. Heath, A. W., Chang, R., Harada, N., Santo-Sargumedo, L., Gordon, J., Hannum, C., Campbell, D., Shanafelt, A. B., Clark, E. A., Torres, R. and Howard, M. (1993). Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell Immunol., 152, 468-480.
94. Defrance, T., Vanbervliet, B., Durand, I., Briolay, J. and Banchereau. J. (1992). Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens. Eur. J. Immunol., 22, 2831-2839.
95. Fluckiger, A. C., Rossi, J. F., Bussel, A., Bryon, P., Banchereau, J. and Defrance, T. (1992). Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood, 80, 3173-3181.
96. Rousset, F., Garcia, E. and Banchereau, J. (1991) Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med., 173, 705-710.
97. Defrance, T., Vanbervliet, B., Brière, F., Durand, I., Rousset, F. and Banchereau, J. (1992). Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med., 175, 671-682.
98. + T cell clones J. Exp. Med., 173, 747-750.
99. Shapira, S. K., Vercelli, D., Jabara, H. H., Fu, S. M. and Geha, R. S. (1992). Molecular analysis of the induction of immunoglobulin E synthesis in human B cell by interleukin 4 and engagement of CD40 antigen J. Exp. Med., 175, 289-292.
100. Gauchat, J. F., Aversa, G., Gascan, H. and de Vries, J. E. (1992). Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production Int Immunol., 4, 397-406
101. Punnonen, J., Aversa, G. G., Cocks, B. G., McKenzie, A. N. J., Menon, S., Zurawski, G., de Waal Malefyt, R. and de Vries, J. E. (1993). Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells Proc. Natl. Acad Sci. USA. 90, 3730-3734.
102. Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D.-H., Kastelein, R., Moore, K. W. and Banchereau, J. (1992). Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Prac. Natl. Acad. Sci. USA. 89, 1890-1893.
103. Briere, F., Servet-Delprat, C., Bridon, J.-M., Saint-Remy, J.-M. and Banchereau, J. (1994). Human interleukin 10 induces naive slgD+ B cells to secrete IgG1 and IgG3. J. Exp. Med., 179, 757-762.
104. Coffman, R. L., Lebman, D. A. and Shrader, B. (1989). Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med., 170, 1039-1045.
105. Parker, D. C. (1993). T cell-dependent B cell activation. Anna. Rev. Immunol., 11, 331-360.
106. Noelle, R. J. and Snow, E. C. (1990). Cognate interactions between helper T cells and B cells. Immunol. Today. 11, 361-368
107. Lipsky, P. E. (1990). The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells A model of T cell/B cell collaboration Res. Immunol., 141, 424-427.
108. Noelle, R. J., McCann, J., Marshall, L. and Bartlett, W. C. (1989). Cognate interactions between helper B cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells. J. Immunol.,143, 1807-1814.
109. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A and Aruffo, A. (1992). A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA, 89, 6550-6554.
110. Splawski, J. B., Fu, S. M. and Lipsky, P. E. (1993). Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol., 150, 1276-1285.
111. Notarangelo, L. D., Duse, M. and Ugazio, A. G. (1992). Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev., 3, 101-121.
112. Facchetti, F., Appiant, C., Salvi, L., Levy, J and Notarangelo, L. D. (1995). Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J. Immunol., 154, 6624-6633.
113. Saiki, O., Tanaka, T., Wada, Y., Uda, H., Inoue, A., Katada, Y., Izeki, M., Iwata, M., Nunoi, H., Matsuda, I., Kinoshita, N. and Kishimoto, T. (1995). Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J. Clin. Invest., 95, 510-514.
114. Durandy, A., Schiff, C., Bonnefoy, J. Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M. and Fischer, A. (1993) Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG. IGa and IgE production by B cells from patients with X-linked hyper-IgM syndrome. Eur. J. Immunol., 23, 2294-2299.
115. Castle, B. E., Kishimoto, K., Stearns, C., Brown, M. L. and Kehry, M. R. (1993). Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol., 151, 1777-1788.
116. Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A. and Noelle, R. J. (1993) The regulation of the expression of gp39. the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol.,151, 2497-2510.
117. Fuleihan, R., Ahern, D. and Geha, R. S. (1995). Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switching. Int. Arch. Allergy Immunol., 107, 43-44.
118. Yellin, M. J., Sippel, K., Inghirami, G., Covey, L. R., Lee, J. J., Sinning, J., Clark, H. A., Chess, L. and Lederman, S. (1994). CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40L. Potential role in regulating helper effector function J. Immunol., 152, 598-608.
119. Lederman, S., Yellin, M. J., Inghirami, G., Lee, J. J., Knowles, D. M. and Chess, L. (1992). Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. J. Immunol., 149, 3817-3826.
120. van den Eertwegh, A. J. M., Noelle, R. J., Roy, M., Shepherd. D. M., Aruffo, A., Ledbetter, J. A., Bocrsma, W. J. A. and Claassen, E. (1993). CD40-gp39 interactions are essential for thymus dependent humoral immunity and identify sites of cognate interactions in vivo. J. Exp. Med., 178, 1555-1565.
121. Gauchat, J.-F., Henchoz, S., Mazzei, G., Aubry, J.-P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., Thompson, J., Kishi, K., Butterfield, J., Dahinden, C. and Bonnefoy, J.-Y. (1993). Induction of human IgE synthesis in B cells by mast cells and basophils. Nature, 365, 340-343.
122. Gauchat, J.-F., Henchoz, S., Fattah, D., Mazzei, G., Aubry, J.-P., Jomotte, T., Dash, L., Page, K., Solari, R., Aldebert, D., Capron, M., Dahinden, C. and Boonefoy, J.-Y. (1995). CD40 ligand is functionally expressed on human eosinophils. Eur J. Immunol., 25, 863-865.
123. Ware, C. F., Crowe, P. D., Vanarsdale, T. L., Andrews, J. L., Grayson, M. H., Jerzy, R., Smith, C. A. and Goodwin, R. G. (1991). Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol., 147, 4229-4238.
124. Armitage, R. J., Maliszewski, C. R., Alderson, M. R., Grabstein, K. H., Spriggs, M. K. and Fanslow, W. C. (1993). CD40L: A multi-functional ligand. Semin. Immunol.,5, 401-412.
125. Armitage, R. J., Tough, T. W., Macduff, B. M., Fanslow, W. C., Spriggs, M. K., Ramsdell, F. and Alderson, M. R. (1993). CD40 ligand is a T cell growth factor. Eur. J. Immunol., 23, 2326-2331.
126. Fanslow, W. C., Clifford, K. N., Seaman, M., Alderson, M. R., Spriggs, M. K., Armitage, R. J. and Ramsdell, F. (1994). Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol., 152, 4262-4269
127. Ramsdell, F., Seaman, M., Clifford, K. N. and Fanslow, W. C. (1994). CD40 ligand acts as a costimulatory signal for neonatal thymic γδ T cells. J Immunol., 152, 2190-2197.
128. Splawski, J. B., Nishioka, J., Nishioka, Y. and Lipsky, P. E. (1996). CD40 ligand is expressed and functional on activated neonatal T cells. J. Immunol., 156, 119-127.
129. + T lymphocytes. J. Immunol., 152, 1523-1531.
130. Grewal, I. S., Xu, J. and Flavell, R. A. (1995). Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378, 617-620.
131. van Essen, D., Kikutani, H. and Gray, D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature, 378, 620-623.
132. Le, J. and Vilcek, J. (1987) Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest.,56, 234-248.
133. Landis, R. C., Friedman, M. L., Fisher, R. I. and Ellis, T. M. (1991). Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals. J. Immunol., 146, 128-135.
134. Webb, D. S., Shimizu, Y., Van Seventer, G. A., Shaw, S. and Gerrard, T. L. (1990). LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science, 249, 1295-1297.
135. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C. and Spriggs, M. K. (1993). CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp. Med., 178, 669-674.
136. Kiener, P. A., Moran-Davis, P., Rankin, B. M., Wahl. A. F., Aruffo, A. and Hollenbaugh, D. (1995). Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol., 155, 4917-4925.
137. Wagner, D. H., Stout, R. D. and Suttles, J. (1994). Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J. Immunol.,24, 3148-3154.
138. Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M. and Delespesse, G. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J. Immunol.,25, 1125-1128.
139. Stout, R. D., Suttles, J., Xu, J., Grewal, I. S. and Flavell, R. A. (1996). Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol., 156, 8-11.
140. Moreau, I., Duvert, V., Banchereau, J. and Saeland, S. (1993) Culture of human fetal B-cell precursors on bone marrow stroma maintains highly proliferative CD20dim cells. Blood, 81, 1170-1178.
141. Saeland, S., Duvert, V., Caux, C., Pandrau, D., Favre, C., Valle, A., Durand, I., Charbord, P., de Vries, J. and Bancherau, J. (1992). Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp. Hematol., 20, 24-29.
142. Saeland, S., Duvert, V., Moreau, I. and Banchereau, J. (1993). Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med., 178, 113-120.
143. Renard, N., Duvert, V., Blanchard, D., Banchereau, J. and Saeland, S. (1994). Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors. J. Immunol., 152, 1693-1701
144. Caux, C., Yong-Jun, L. and Banchereau, J. (1995). Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol. Today, 16, 2-4.
145. Vyth-Dreese, F. A., Dellemijn, T. A., Majoor, D. and de Jong, D. (1995). Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur. J. Immunol., 25, 3023-3029.
146. Pequet-Navarro, J., Dalbiez-Gauthier, C., Rattis, F. M., van Kooten, C., Banchereau, J. and Schmitt, D. (1995). Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol., 155, 4241-4247.
147. Romani, N., Lenz, A., Glassl, H., Stossel, H., Stanzl, U., Majdic, O., Fritsch, P. and Schuler, G. (1989). Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol.,93, 600-609.
148. Caux, C., Dezutter-Dambuyant, C., Smitt, D. and Banchereau, J. (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 360, 258-261
149. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J. (1994). Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med., 180, 1263-1272.
150. Clark, E. A., Grabstein, K. H. and Shu, G. L. (1992). Cultured human follicular dendritic cells. Growth characteristics and interactions with B lymphocytes. J. Immunol., 148, 3327-3335.
151. Schriever, F., Freedman, A. S., Freeman, G., Messner, E., Lee, G., Daley, J. and Nadler, L. M. (1989). Isolated human follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med., 169, 2043-2058.
152. Gray, D. (1993) Immunological memory. Annu. Rev. Immunol., 11, 49-77.
153. Lensehow, D and Bluestone, J. (1993). T cell co-stimulation and in vivo tolerance. Curr. Opin. Immuno.,5, 747-752.
154. June, C., Bluestone, J., Nadler, L. and Thompson. C. (1994). The B7 and CD28 receptor families. Immunol. Today, 15, 321-331.
155. Dune, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J. (1994). The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today. 15, 406-411.
156. Springer, T. A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm. Cell. 76, 301-314.
157. Carlos, T. M. and Harlan, J. M. (1994). Leukocyte-endothelial adhesion molecules. Blood, 84, 2068-2101.
158. Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D. and Chess, L. (1995). Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med., 182, 1857-1864.
159. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A. and Aruffo, A. (1995). Expression of functional CD40 by vascular endothelial cells. J. Exp. Med., 182, 33-40.
160. Karmann, K., Hughes, C. C. W., Schechner, J., Fanslow, W. C. and Pober, J. S. (1995). CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA, 92, 4342-4346.
161. Karmann, K., Hughes, C. C. W., Fanslow, W. C. and Pober, J. S. (1996). Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway. Eur. J. Immunol., 26, 610-617.
162. Galy, A. H. M. and Spits, H. (1992). CD40 is functionally expressed on human thymic epithelial cells. J. Immunol., 149, 775-782
163. Foy, T. M., Page, D. M., Waldschmidt, T. J., Schoneveld, A., Laman, J. D., Masters, S. R., Tygrett, L., Ledbetter, J. A., Aruffo, A., Claassen, E., Xu, J. C., Flavell, R. A., Oehen, S., Hedrick, S. M. and Noelle, R. J. (1995). An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med., 182, 1377-1388.
164. Hess, S. and Engelmann, H. (1996). A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med., 183, 159-167.
165. Fraser, J., Straus, D. and Weiss. A. (1993). Signal transduction events leading to T-cell lymphokine gene expression. Immunol. Today, 14, 357-362.
166. Inghirami, G., Lederman, S., Yellin, M. J., Chadburn, A., Chess, L. and Knowles, D. M. (1994). Phenotypic and functional characterization of T-BAM (CD40 ligand) T-cell non-Hodgkin's lymphoma. Blood, 84, 866-872.
167. Carbone, A., Gloghini, A., Gruss, H.-J. and Pinto, A. (1995). CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphomas and Hodgkin's disease. Am. J. Pathol., 147, 912-922
168. Dijkstra, N. H., Planken, E. V., Bakkus, M., Willemze, R and Kluin-Nelemans, J. C. (1995). Proliferation of precursor B-ALL by triggenng the CD40 antigen. Blood, 86 (Suppl.1): 174a, 684.
169. Renards, N., Durand, I., Duvert, V., Coignet, L., Lafage-Pochitaloff, M., Banchereau, J. and Saeland, S. (1995). Activated CD4+ T cells can induce CD40-dependent proliferation and maturation of B lineage acute lymphoblastic leukemia cells. Blood, 86 (Suppl.1): 776a, 3092.
170. Francisco, J. A., Gilliland, L. K., Stebbins, M. R., Norris, N. A., Ledbetter, J. A. and Siegall, C. B. (1995). Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. Cancer Res.,55, 3099-3104.
171. Carbone, A., Gloghini, A., Gattei, V., Aldmucci, D., Degan, M. Paoli, P. D., Zagonel, V. and Pinto, A. (1995). Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood, 85, 780-789
172. Schlaifer, D., Krajewski, S., Rigal-Huguet, F., Meggetto, F., Pris, J., Massip, P., Laurent, G., Marchou, B., Delsol, G., Reed, J. C. and Brousset, P. (1995). Expression of apoptosis-regulating genes in AIDS-related lymphomas. Blood, 86 (Suppl.1): 380a, 1508.
173. Defrance, T., Fluckiger, A. N., Rossi, J. F., Rousset, F. and Banchereau, J. (1991). In vitro activation of B-CLL cells. Leuk. Lymphoma, 7, 13-19.
174. Crawford, D. H. and Catovsky, D. (1993). In vitro activation of leukemic B-cells by interleukin-4 and antibodies to CD40. Imunology, 80, 40-44.
175. Johnson, P. W. M., Watt, S. M., Betts, D. R., Davies, D., Jordan, S., Norton, A. J. and Lister, T. A. (1993). Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood, 82, 1848-1857.
176. Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H. and Levy, R. (1990). Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clone. J. Immunol., 144, 2550-2557.
177. Kluin-Nelemans, H. C., Baverstock, G. C., Mollevanger, P., Wessels, H. W., Hoogendorn, E., Willemze, R. and Falkenburg, J. H. F. (1994). Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood, 84, 3134-3141.
178. Panayiotidis, P., Ganeshaguru, K., Jabbar, S. A. and Hoffbrand, A. V. (1993). Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol., 85, 439-445.
179. Ranheim, E. A. and Kipps, T. J. (1995). Tumor necrosis factor-α facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T-cells: complex regulation by IL-4, IL-10, and CD40L. Cell. Immunol., 161, 226-235.
180. Lotz, M., Ranheim, E. and Kipps, T. J. (1994). Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J. Exp. Med., 179, 999-1004.
181. Funakoshi, S., Longo, D. L., MBeckwith, M., Conley, D. K., Tsarfaty, G., Tsarfaty, I., Armitage, R. J., Fanslow, W. C., Spriggs, M. K. and Murphy, W. J. (1994). Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood. 83, 2787-2794.
182. Sumimoto, S.-I., Heike, T., Kanazashi, S.-I., Shintaku, N., Jung, E.-Y., Hata, D., Katamura, K. and Mayumi, M. (1994). Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking. J. Immunol.,153, 2488-2496.
183. Funakoshi, S., Longo, D. L., Asai, O., Beckwith, M., Klinke, R., Fanslow, W. C. and Murphy, W. J. (1995). Inhibition of aggressive histology human B-cell lymphoma growth by soluble recombinant human CD40 ligand. Blood, 86 (Suppl.1). 602a, 2397.
184. Fluckiger, A.-C., Durand, I. and Banchereau, J. (1994). Interleukin 10 induces apoptotic death of B-chronic lymphocytic leukemia cells. J. Exp. Med.,179, 91-99.
185. rd international workshop on human leucocyte differentiation antigens. Clin. Exp. Immunol., 72, 351-356.
186. Hamilton, M. S., Ball, J., Bromidge, E. and Franklin, I. M. (1991). Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. Br. J. Haematol., 78, 60-65.
187. Westendorf, J. J., Ahmann, G. J., Armitage, R. J., Spriggs, M. K., Lust, J. A., Greipp, P. R., Katzmann, J. A. and Jelinek, D. F. (1994). CD40 expression in malignant plasma cells - role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol., 152, 117-128.
188. Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harosseau, J.-L. and Rapp, M.-J. (1994). Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood. 84, 2597-2603.
189. Tong, A. W., Zhang, B.-Q., Mues, G., Solano, M., Hanson, T. and Stone, M. J. (1994). Anti-CD40 antibody binding modulates human multiple myeloma clonogenecity in vitro. Blood. 84, 3026-3033.
190. Urashima, M., Chauhan, D., Uchiyama, H., Freeman, G. J. and Anderson, K. C. (1995). CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood, 85, 1903-1912.
191. Westendorf, J. J., Ahmann, G. J., Lust, J. A., Tschumper, R. C., Greipp, P. R., Katzmann, J. A. and Jelinek, D. F. (1995). Molecular and biological role of CD40 in multiple myeloma. Curr. Top. Microbiol. Immunol., 194, 63-72.
192. Carbone, A., Gloghini, A., Zagonel, V., Aldinucci, D., Gattei, V., Degan, M., Improta, S., Sorio, R., Monfardini, S. and Pinto, A. (1995). The expression of CD26 and CD40L is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood, 86, 4617-4626.
193. Armitage, R. J., Macduff, B. M. and Fanslow, W. C. (1995). Distinct patterns of inhibition by CD40 mAb of the CD40 ligand: CD40 interaction. In Leucocyte Typing V, edited by S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd. pp. 551-552. Oxford: Oxford University Press.
194. Casamayor-Palleja, M., Khan, M. and MacLennan, I. C. M. (1995). A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med., 181, 1293-1301.
195. Borowitz, M. J., Weidner, A., Olsen, E. A. and Picker, L. J. (1993). Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associating antigen expression on T cells correlates with extent of disease. Leukemia. 7, 859-863.
196. Nagatani, T., Matsuzaki, T., Iemoto, G., Kim, S., Baba, N., Miyamoto, H. and Nakajima, H. (1990). Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analysis. Cancer,66, 2380-2386.
197. DeCoteau, J. F. and Kadin, M. E. (1995). New insights into peripheral T-cell lymphomas. Curr Opin. Oncol.,7, 408-414.
198. Pinto, A., Aldinucci, D., Carbone, A., Gattei, V., Zagonel, V., Improta, S., Degan, M., De Juliis, A., Gloghini, A. and Gruss, H.-J. (1996). Identification of a novel subset of human acute myeloid leukemias expressing CD40 and showing a proliferative response to CD40 ligand. Blood, Submitted
199. Grass, H.-J., Liedtke, M., Armitage, R. J., Pinto, A., Herrmann, F. and Ludwig, W.-D. (1996). Frequent functional coexpression of CD40 and CD30L on acute lymphoblastic leukemia cells. Blood, Submitted.
200. Reid, C. D. L., Fryer, P. R., Clifford, C., Kirk, A., Tikerpae, J. and Knight, S. C. (1990). Identification of hematopoietic progenitors of macrophage and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood,76, 1139-1149.
201. Reid, C. D. L., Stackpole, A., Meager, A. and Tikerpae, J. (1992). Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol., 149, 2681-2688
202. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinmann, R. M. and Schuler, G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180, 83-93.
203. Young, L. W., Szabolcs, P. and Moore, M. A. S. (1995). Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J Exp. Med., 182, 1111-1120.
204. Santiago-Schwarz, F., Coppock, D. L., Flindenburg, A. A. and Kern, J. (1994). Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood,84, 3054-3062.
205. Asimakopulos, F. A., White, N. J., Nacheva, E. P. and Green, A. R. (1994) Molecular analysis of chromosome 20 deletions associated with myeloprohferative disorders and myelodysplastic syndromes. Blood, 84, 3086-3094.
206. Asimakopulos, F. A., White, N. J., Nacheva, E. P. and Green, A. R. (1996). The human CD40 gene ties within chromosome 20q deletions associated with myeloid malignancies. Br. J. Haematol.,92, 127-130.
207. Kennedy, I. C., Hart, D. N., Colls, B. M., Nimmo, J. C., Willis, D. A and Angus, H. B. (1989). Nodular sclerosing. mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies. Clin. Exp. Immunol., 76, 324-331.
208. Gruss, H.-J., Herrmann, F. and Drexler, H. G. (1994). Hodgkin's disease: a cytokine producing tumor. Crit. Rev. Oncogenesis.5, 473-538
209. Gruss, H.-J., Hirschstein, D., Wright, B., Ulrich, D., Caltgiuri, M. A., Barcos, M., Strockbine, L., Armitage, R. J. and Dower, S. K. (1994). Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood, 84, 2305-2314.
210. Schwab, U., Stein, H., Gerdes, J., Lemke, H., Kirchner, H., Schaadt, M and Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature, 299, 65-67.
211. Falini, B., Piled, S., Pizzolo, G., Dürkop, H., Flenghi, L., Stirpe, F., Martelli, M. F. and Stein, H. (1995). CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood, 85, 1-14.
212. O'Grady, J. T., Stewart, S., Lowrey, J., Howie, S. E. and Krajewski, A. S. (1994). CD40 expression in Hodgkin's disease. Am. J. Pathol., 144, 21-26
213. Carbone, A., Gloghini, A., Gruss, H.-J. and Pinto, A. (1995). CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease. Am. J. Pathol., 146, 780-781.
214. Murray, P. G., Oates, J., Reynolds, G. M., Crocket, L. and Young, L. S. (1995). Expression of B7 (CD80) and CD40 antigen and the CD40 ligand in Hodgkin's disease is independent of latent Epstein-Barr virus infection. J. Clin. Pathol. Mol. Pathol., 48, 105-108.
215. Nadali, G., Vinante, F., Ambrosetti, A., Todeschini, G., Veneri, D., Zanotti, R., Meneghini, V., Ricetti, M. M., Benedetti, F., Vassanelli, A., Perona, G., Chilosi, M., Menestrina, F., Fiacchini, M., Stein, H. and Pizzolo, G. (1994). Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J. Clin. Oncol., 12, 793-797.
216. Gruss, H.-J., Ulrich, D., Dölken, G., Armitage, R. J., Herrmann, F. and Pinto, A. (1996). Release of soluble CD40 antigen by Hodgkin's disease cells. Eur. J. Immunol., Submitted.
217. Gruss, H.-J., Ulrich, D., Braddy, S., Armitage, R. J. and Dower, S. K. (1995). Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Stemberg cells. Eur. J. Immunol. 25, 2083-2089.
218. Chittal, S. M., Caveriviere, P., Schwarting, R., Gerdes, J., Al Saati, T., Rigal-Huguet, F., Stein, H. and Delsol, G. (1988). Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. Am. J. Surg. Pathol., 12, 9-21.
219. Carbone, A., Gloghini, A. and Volpe, R. (1992). Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Virchows Arch A Pathol Anat. Histopathol., 420, 527-532.
220. Drexler, H. G. (1992). Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk. Lymphoma, 8, 283-313.
221. Medeiros, J. L., Lardelli, P., Stetler-Stevenson, M., Longo, D. L. and Jaffe, E. S. (1991). Genotypic analysis of diffuse, mixed cell lymphomas. Am., J. Clin. Pathol., 95, 547-555.
222. Mirchandani, I., Palutke, M., Tabaczka, P., Goldfarb, S., Eisenberg, L. and Pak. M. S. (1985). B-cell lymphomas morphologically resembling T-cell lymphomas. Cancer. 56, 1578-1583.
223. Osbome, B. M., Butler, J. J. and Pugh, W. C. (1990). The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: lineage confirmed by JH rearrangement. Ant. J. Surg. Pathol., 14, 933-938.
224. Ramsay, A. D., Smith, W. J and Isaacson, P. G. (1988). T-cell-rich B-cell lymphoma. Am. J. Surg. Pathol., 12, 433-443.
225. Scarpa, A., Bonetti, F., Zamboni, G., Menestrina, F. and Chilosi, M. (1989). T-cell-rich B-cell lymphoma. Am. J Surg. Pathol., 13, 335-337.
226. Stein, H., Mason, D. Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R. and Lennert, K. (1985). The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848-858.
227. Merz, H., Houssiau, F. A., Orscheschek, K., Renauld, J. C., Fliedner, A., Herin, M., Noel, H., Kadin, M., Müller-Hermelink, H.-K., Van Snick, J and Feller, A. C. (1991). Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood, 78, 1311-1317.
228. Delabie, J., Shipman, R., Bruggen, J., De Strooper, B., van Leuven, F., Tarcsay, L., Cerletti, N., Odink, K., Diehl, V., Bilbe, G. and De Wolf-Peeters, C. (1992). Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. Blood, 80, 2891-2896.
229. Pinto, A., Gloghini, A., Gattei, V., Aldinucci, D., Zagonel, V. and Carbone, A. (1994). Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood, 83, 785-792.
230. Rosso, R., Paulli, M., Magrini, U., Kindl, S., Boveri, E., Volpato, G., Poggi, S., Baglioni, P. and Pileri, S. (1990). Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Virchows Arch. A Pathol. Anat Histopathol., 416, 229-235.
231. Carbone, A., Cozzi, M., Gloghini, A. and Pinto, A. (1994). CD26/DPPIV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Hum. Pathol., 25, 1360-1365.
232. Carbone, A., Gloghini, A., Zagonel, V. and Pinto, A. (1995). An update on the diagnostic relevance of CD26 antigen expression in CD30 positive anaplastic large cell lymphomas. Hum. Pathol.,26, 1169-1170.
233. Nishioka, Y. and Lipsky, P. E. (1994). The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol., 153, 1027-1036.
234. Klippers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R. and Hansmann, M.-L. (1994). Hodgkin disease: Hodgkin and Reeed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad Sci. USA, 91, 10962-10966.
235. Delabie, J., Tierens, A., Wu, G., Weisenburger, D. D. and Chan, W. C. (1994). Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood, 84, 3291-3298.
236. Hummel, M., Ziemann, K., Lammert, H., Pileri, S., Sabattini, E. and Stein, H. (1995). Hodgkin's disease with monoclonal and polyclonal populations of Reed-Stemberg cells. N. Engl. J. Med., 333, 901-906.